Aripiprazole Tablet
Product Images NDC 82804-023

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Aripiprazole (NDC 82804-023). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure (Aripiprazole Fig1)

Figure (Aripiprazole Fig1)
FDA Label Image

82804-023-30 (Aripiprazole Fig12)

82804-023-30 (Aripiprazole Fig12)
FDA Label Image

Figure (Aripiprazole Fig2)

Figure (Aripiprazole Fig2)
FDA Label Image

Figure (Aripiprazole Fig3)

Figure (Aripiprazole Fig3)
FDA Label Image

Figure (Aripiprazole Fig4)

Figure (Aripiprazole Fig4)
FDA Label Image

Figure (Aripiprazole Fig5)

Figure (Aripiprazole Fig5)
FDA Label Image

Figure 6: Kaplan-meier Estimation Of Cumulative Proportion Of Patients With Relapse (schizophrenia Study 5) (Aripiprazole Fig6)

Figure 6: Kaplan-meier Estimation Of Cumulative Proportion Of Patients With Relapse (schizophrenia Study 5) (Aripiprazole Fig6)
Figure 6 shows the Kaplan-Meier estimation of the cumulative proportion of patients with relapse in Schizophrenia Study 5. The figure includes data for both the Aripiprazole and Placebo groups. The x-axis represents the number of days from randomization, and the y-axis represents the proportion of patients with relapse. The data consists of the number of subjects at risk for relapse at each time point for both the Aripiprazole and Placebo groups.*
FDA Label Image

Figure 9: Least Square Means Of Change From Baseline In Ygtss Tts By Week (tourette’s Disorder Study 1) (Aripiprazole Fig7)

Figure 9: Least Square Means Of Change From Baseline In Ygtss Tts By Week (tourette’s Disorder Study 1) (Aripiprazole Fig7)
This text appears to be a chart or graph showing the change in YGTSS (Yale Global Tic Severity Scale) total TIC score over time, specifically comparing the effect of low dosage and high dosage of a medication called Aripiprazole, as well as a placebo. The chart displays the number of weeks of treatment on the X-axis and the change in the YGTSS total TIC score on the Y-axis. The values in the chart indicate that there was no change at week 0, a decrease of 5 at week 1, and no change again at week 2 and 4. The specific nature of the change or the study is not clear from the given text.*
FDA Label Image

Aripiprazole Structure (Aripiprazole Str)

Aripiprazole Structure (Aripiprazole Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.